Search results for: PhRMA
Filter search results
Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment—Rationale and Empirical Support
14 April 2020
…Manufacturers of America (PhRMA). The full article has been published as an open access licence and can be accessed on the Journal of Managed Care & Specialty Pharmacy website here….
Press Release: Proposed International Price Index Effectively Outsources Pharmaceutical Policy Decisions to Other Countries
29 October 2019
…was funded by PhRMA through OHE Consulting Ltd, a subsidiary of the Office of Health Economics. Contact Details Office of Health Economics 7th Floor Southside 105 Victoria Street London, UK…
A Market-based International Reference Price Index: Solution or Contradiction?
13 September 2019
…and Singapore can make medicines more affordable in the U.S. (Jan 18, 2019). Available at: https://freopp.org/what-medicare-can-learn-from-other-countries-on-drug-pricing-bf298d390bc5 Acknowledgement of funding: The analysis underpinning this blog was undertaken with funding from PhRMA…
Moving the Needle on Value – OHE Launches Research on US Value-Based Healthcare
10 June 2019
…by PhRMA. Graham was joined by the Innovation and Value Institute’s Executive Director Jenn Bright, and Harvard Medical School Professor Bapu Jena. OHE and The Value Collaborative, an initiative of…
Adrian Towse named 2018 Value Assessment Challenge Award Recipient
22 October 2018
…the 2018 Value Assessment Challenge Awards designed to encourage innovative approaches in defining and measuring value in health care. The PhRMA Foundation and the Personalized Medicine Coalition (PMC) announced that…
Recently Published: Reports on Policy Options for Formulary Development in Middle-income Countries and A Case Study from Mexico
4 January 2017
…system as a case study. A number of middle-income countries (MICs) are evolving their health systems toward universal health coverage for patient populations. PhRMA commissioned OHE Consulting to explore options…
OHE at ISPOR Latin America: Policy Options for Formulary Development in Middle-income Countries
20 October 2015
…coverage. The first presentation by Martina Garau presented initial results of a study undertaken by OHE and the University of Washington, funded by PhRMA, which sets out possible policy approaches…
Spotlight on OHE: Development and Use of Measures of Health Worldwide
16 July 2012
…to sessions at a June PhRMA meeting on Health Technology Assessment in Latin American. (For the OHE report on this, click here.) At ISPOR in June, Adrian participated on a…
How is Quality of Life Measured for Health Technology Assessments?
1 July 2021
Cost-effectiveness analysis (CEA) is the economic evaluation method that is typically preferred by health technology assessment agencies. Quality-adjusted life years (QALYs) – a composite measure of quality and quantity of life – are often…